All > Hernia

Gore ENFORM Biomaterial (Preperitoneal) for Incisional Hernia

Phase-Based Progress Estimates
1
Effectiveness
1
Safety
Incisional Hernia+3 MoreGore ENFORM Biomaterial (Preperitoneal) - Device
Eligibility
18+
All Sexes
What conditions do you have?
Select

Study Summary

This trial is testing a new device to see if it works better than current devices for hernia repair.

Eligible Conditions
  • Incisional Hernia
  • Hiatal Hernia
  • Ventral Hernia
  • Diaphragmatic Hernia

Treatment Effectiveness

Effectiveness Progress

1 of 3

Similar Trials

1
Vermont RETAIN
1
Phasix™ Mesh
1
Abdominal Wall Transplant

Study Objectives

4 Primary · 4 Secondary · Reporting Duration: Through 24 months

Day 1
Incidence of SSI - Primary Procedural Endpoint 1
Incidence of SSO - Primary Procedural Endpoint 2
Incidence of SSOPI - Primary Procedural Endpoint 3
Through 24 months
Change in Quality of Life in Carolinas Comfort Scale - Secondary Endpoint 3
Freedom from potential device-related SAEs - Secondary endpoint 1
Hernia Recurrence - Primary Device Endpoint
Re-intervention at study-treated location - Secondary Endpoint 2
Relief from GERD Symptoms - Secondary Endpoint 4

Trial Safety

Safety Progress

1 of 3

Similar Trials

1
Vermont RETAIN
1
Phasix™ Mesh
2
Abdominal Wall Transplant

Trial Design

4 Treatment Groups

Ventral/Incisional Hernia - Intraperitoneal ENFORM Biomaterial
1 of 4
Hiatal/Diaphragmatic Hernia-Intraperitoneal ENFORM Biomaterial
1 of 4
Ventral/Incisional Hernia - Preperitoneal ENFORM Biomaterial
1 of 4
Hiatal/Diaphragmatic Hernia - Preperitoneal ENFORM Biomaterial
1 of 4

Experimental Treatment

245 Total Participants · 4 Treatment Groups

Primary Treatment: Gore ENFORM Biomaterial (Preperitoneal) · No Placebo Group · N/A

Ventral/Incisional Hernia - Intraperitoneal ENFORM Biomaterial
Device
Experimental Group · 1 Intervention: Gore ENFORM Biomaterial (Intraperitoneal) · Intervention Types: Device
Hiatal/Diaphragmatic Hernia-Intraperitoneal ENFORM Biomaterial
Device
Experimental Group · 1 Intervention: Gore ENFORM Biomaterial (Intraperitoneal) · Intervention Types: Device
Ventral/Incisional Hernia - Preperitoneal ENFORM Biomaterial
Device
Experimental Group · 1 Intervention: Gore ENFORM Biomaterial (Preperitoneal) · Intervention Types: Device
Hiatal/Diaphragmatic Hernia - Preperitoneal ENFORM Biomaterial
Device
Experimental Group · 1 Intervention: Gore ENFORM Biomaterial (Preperitoneal) · Intervention Types: Device

Trial Logistics

Trial Timeline

Screening: ~3 weeks
Treatment: Varies
Reporting: through 24 months

Who is running the clinical trial?

W.L.Gore & AssociatesLead Sponsor
87 Previous Clinical Trials
23,704 Total Patients Enrolled
2 Trials studying Incisional Hernia
424 Patients Enrolled for Incisional Hernia
Todd Heniford, MDPrincipal InvestigatorWake Forest University Health Sciences
3 Previous Clinical Trials
343 Total Patients Enrolled

Eligibility Criteria

Age 18+ · All Participants · 5 Total Inclusion Criteria

Mark “Yes” if the following statements are true for you:
You are willing to provide informed consent and comply with follow-up requirements.
References

Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top